How Often Does Diverticulitis Turn Into Cancer?

Diverticulitis does not appear to transform into colorectal cancer in any meaningful biological sense. When researchers track patients for years after an episode of diverticulitis, the long-term risk of developing colon cancer is not elevated compared to the general population. What muddies the picture is that cancer is sometimes found shortly after a diverticulitis diagnosis, usually because the cancer was already there and either triggered symptoms that looked like diverticulitis or was caught during the follow-up workup. That distinction between “turning into” cancer and “hiding behind” a diverticulitis diagnosis matters enormously for understanding your actual risk.

Cancer Detection Rates After a Diverticulitis Episode

When patients undergo colonoscopy after recovering from acute diverticulitis, colorectal cancer is found in a small but non-trivial percentage. Estimates from multiple studies put the rate somewhere between roughly 1% and 5%, depending on the patient population and whether the diverticulitis was complicated or uncomplicated. One large review estimated the prevalence of colorectal cancer at about 1.9% to 2.3% in the overall diverticulitis population.¹ A study of 252 patients who had colonoscopy after diverticulitis found colorectal cancer in about 3.2%.² Another study of 205 patients who had colonic evaluation after uncomplicated diverticulitis found a cancer rate of just 0.5%, though about 5% had advanced neoplasia of some kind, including precancerous polyps.³

These numbers are worth putting in context. The cancer being found in these patients was almost always already present at the time of the diverticulitis episode. The colonoscopy performed afterward simply revealed it. In a study of more than 17,000 patients who underwent surgery for what was thought to be acute diverticulitis, fewer than 1% turned out to have an unexpected cancer diagnosis on the pathology report afterward.⁴ So even among people sick enough to need surgery, the hidden-cancer rate was under one in a hundred.

The Detection Bias Problem

A large nationwide cohort study from Denmark found that patients with diverticular disease had about a 70% higher risk of being diagnosed with colon cancer compared to controls, with an adjusted hazard ratio of 1.71.⁵ At first glance, that sounds alarming. But the same study noted that this increased risk was primarily restricted to the first year of follow-up and especially involved early-stage cancers. That pattern is the hallmark of detection bias, not of a genuine causal link. People who have diverticulitis get imaging and colonoscopies they might not otherwise have received, which catches cancers that were already growing silently.

A separate Danish register-based study found a very similar pattern. The initial hazard ratio for colon cancer in the diverticulitis group was 1.7. But when the researchers ran a sensitivity analysis that excluded the first six months after diagnosis, the hazard ratio actually flipped below 1.0, landing at 0.8. In other words, once you removed that early detection window, people with diverticulitis were actually slightly less likely to be diagnosed with colon cancer than the general population.⁶ That reversal makes a strong case that the early spike is about finding existing cancers, not about diverticulitis causing new ones.

Long-Term Risk Is Not Elevated

The most reassuring evidence comes from a systematic review and meta-analysis that pooled findings across multiple studies and concluded that the long-term risk of colon cancer after diverticulitis is not increased.⁷ The authors recommended that follow-up after a diverticulitis episode should focus on the short-term window, where the goal is to rule out a cancer that might be masquerading as diverticulitis, rather than on years-long cancer surveillance.

This finding lines up neatly with the individual cohort studies. The elevated risk everyone sees in the first months after diagnosis disappears with time, suggesting that diverticulitis and colon cancer share symptoms and imaging features but not a causal pathway. Your inflamed colon pouch is not on a trajectory toward malignancy. The inflammation of diverticulitis and the cellular changes that produce cancer are biologically different processes, even though they happen in the same neighborhood of the body.

Complicated Diverticulitis Is a Different Story

The distinction between uncomplicated and complicated diverticulitis turns out to be the single most important variable in predicting whether cancer will be found. Uncomplicated diverticulitis means you had inflammation but no abscess, perforation, fistula, or obstruction. Complicated diverticulitis involves one or more of those serious features, and it carries a substantially higher chance of having a concurrent cancer discovered.

In one study, patients with complicated diverticulitis had rates of advanced colorectal neoplasia around 21%, compared to about 6% in the uncomplicated group.² A broader review estimated the cancer prevalence in complicated cases at 6% to 8%, compared to 2% or less in uncomplicated diverticulitis.¹ The reason is not that abscesses and perforations cause cancer. It is more likely that a tumor can cause a bowel obstruction or perforation that gets labeled as complicated diverticulitis on initial imaging, especially when the CT scan is ambiguous.

Chronic strictures from repeated bouts of diverticulitis can also raise clinical suspicion. When scar tissue narrows the sigmoid colon over time, it creates a fixed narrowing that can look and behave much like a tumor-related obstruction. In complicated cases requiring surgical intervention, bowel obstruction from strictures is reported in roughly 10% to 25% of cases.⁸ Sorting out whether a narrowed, thickened segment of colon is scar tissue or tumor often requires tissue samples, not just imaging.

Why Diverticulitis and Cancer Look So Similar on a CT Scan

Part of the confusion stems from the fact that these two conditions can be genuinely difficult to tell apart on imaging. Both diverticulitis and colon cancer cause thickening of the bowel wall, surrounding tissue inflammation, and sometimes obstruction. A classic study using helical CT found that radiologists could confidently and correctly diagnose diverticulitis in only 40% of confirmed cases and colon cancer in 66% of confirmed cases on prospective reads.⁹ That leaves a substantial gray zone where neither diagnosis can be made with confidence from the scan alone.

The overlap is estimated at roughly 10% of cases, meaning that about one in ten times, the imaging appearance of one condition is essentially indistinguishable from the other.¹⁰ This is particularly tricky in the sigmoid colon, where diverticulitis is most common. Both conditions produce a thickened, inflamed segment that can look nearly identical to a radiologist reviewing the images in real time. When there is any ambiguity, clinicians typically recommend follow-up colonoscopy once the acute inflammation has settled down, specifically to get a direct look at the tissue and, if needed, take biopsies.

Age Matters for the Follow-Up Workup

Your age at the time of a diverticulitis episode significantly affects both the likelihood that cancer is lurking and the recommendations for follow-up. In one study of 77 patients who had colonoscopy after diverticulitis, all four colorectal cancers were found in patients aged 50 or older, and no neoplastic lesions of any kind were found in patients younger than 40.¹¹ This aligns with what we know about colorectal cancer in general: it becomes far more common with advancing age, and the base rate in people under 40 is low enough that additional screening yields very little.

A multi-center review of colonoscopy follow-up practices concluded that routine colonoscopy for patients over 50 with uncomplicated diverticulitis is not a cost-effective strategy for cancer screening, since these patients would typically already be participating in standard colorectal cancer screening programs with stool-based tests. The authors suggested that routine endoscopic follow-up still makes sense for patients under 50 with uncomplicated diverticulitis, who would not yet be in those screening programs, and for anyone admitted with complicated diverticulitis regardless of age.¹²

This is a nuanced recommendation that often gets lost in translation. Many patients walk away from a diverticulitis diagnosis worried that they need extra cancer screening on top of what they are already doing. For most people over 50 who had a straightforward, uncomplicated episode, staying current on standard screening is likely sufficient. The people who genuinely benefit from an additional colonoscopy are those with complicated disease or those who are not yet old enough to be in a routine screening program.

What About Chronic or Recurrent Diverticulitis

A common worry is whether repeated flares of diverticulitis could eventually promote cancer through ongoing chronic inflammation. The logic seems intuitive: other chronic inflammatory conditions of the colon, like ulcerative colitis, do raise cancer risk over decades. But the evidence for diverticulitis does not follow that pattern. The meta-analysis finding no long-term increase in cancer risk included patients with recurrent episodes, and the conclusion held.⁷

The inflammation in diverticulitis is fundamentally different from the inflammation in conditions like inflammatory bowel disease. Diverticulitis involves a localized, acute flare centered on a single diverticulum, or sometimes a cluster of them. It tends to be self-limited, responding to antibiotics or resolving on its own, and the surrounding mucosa returns to normal between episodes. Ulcerative colitis, by contrast, involves a continuous, diffuse inflammation of the entire mucosal lining over years to decades, creating an environment of sustained cellular turnover and DNA damage that genuinely does raise cancer risk. The two conditions share the word “inflammation” but little else in terms of the mechanism that links chronic inflammation to malignancy.

The Gut Microbiome Connection

There is growing interest in whether the gut microbiome might link diverticular disease and cancer, since shifts in gut bacteria have been implicated in both conditions separately. A systematic review of the microbiome in diverticular disease found that certain bacterial families, especially Enterobacteriaceae, were most consistently associated with the disease, along with shifts in Bifidobacteria populations.¹³ Some of these same bacterial shifts have been noted in colorectal cancer research as well, which has led to speculation about shared microbiome-driven pathways.

The honest assessment is that this research is still in its early stages. The systematic review included only nine studies, and most examined patients with diverticular disease without active inflammation rather than those with acute diverticulitis. Whether microbiome changes are a cause or a consequence of either condition remains unclear, and no study has yet shown that the bacterial profile seen in diverticular disease directly promotes the cellular changes that lead to cancer. It is an area to watch rather than one that should change anyone’s medical decisions right now.

When to Push for Additional Testing

Even though the long-term cancer risk is not elevated, there are specific situations where pushing for a thorough workup after a diverticulitis episode is wise. The first is any complicated episode involving abscess, perforation, fistula, or obstruction. The cancer prevalence in that group is several times higher than in uncomplicated cases, and missing a cancer that presented as complicated diverticulitis can cost critical staging time.¹

The second is when imaging was ambiguous. If the CT report uses phrases like “cannot exclude malignancy” or “recommend follow-up,” that language exists for a reason. The 10% imaging overlap between diverticulitis and cancer means that a colonoscopy with biopsies is the only reliable way to settle the question when the scan is not definitive. The third is when symptoms do not resolve as expected. Diverticulitis that responds to treatment should improve within days. Ongoing pain, bleeding, weight loss, or a change in bowel habits that persists after the acute episode should prompt further evaluation, because those are the symptoms that cancer and diverticulitis share and that cancer does not relinquish when antibiotics are given.

For the average person who had a single uncomplicated episode, responded well to treatment, and is already up to date on standard colorectal cancer screening, the evidence does not support years of additional colonoscopies beyond what is normally recommended for your age group. The short-term follow-up colonoscopy, typically performed six to eight weeks after the acute episode, is meant to rule out a concurrent cancer and does not need to become a recurring event.

Right-Sided Diverticulitis

Most diverticulitis in Western populations occurs in the sigmoid colon, on the left side. Only about 1% to 5% of diverticula occur in the right colon.¹⁰ Right-sided diverticulitis is more common in Asian populations and tends to occur in younger patients. The diagnostic challenge with right-sided disease is different: it can mimic appendicitis clinically, and on imaging it can look like a right-sided colon cancer, which is itself a distinct entity with different screening implications than left-sided tumors.

Because right-sided diverticulitis is rarer, radiologists have less experience recognizing it, and the imaging features that help distinguish diverticulitis from cancer are less well established on that side of the colon. Patients with right-sided episodes may therefore face a higher likelihood of diagnostic uncertainty and a stronger case for follow-up colonoscopy to rule out malignancy, regardless of whether the episode was technically complicated. If you have been told you have right-sided diverticulitis, asking about a follow-up colonoscopy is reasonable even if the episode was mild.